A similar study also reported that BM-MSCs decreased the percentage of cells producing IFN-γ, TNF-α, IL-17, and IL-2, in naive, effector, and memory T cell subsets from the peripheral blood of RA patients [36,37]. The gene discussed is IL2; the disease is rheumatoid arthritis.